Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$371,112
in 2 filings, $371K under 10b5-1 plans

Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gheuens Sarah −$371K Chief Medical Officer sold 15% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-11-01 Biller Scott Chief Scientific Officer Sale −900 $63.09 $57K 7,210
2017-11-01 Biller Scott Chief Scientific Officer Sale −946 $61.81 $58K 6,264
2017-11-01 Biller Scott Chief Scientific Officer Option exercise · Stock option (right to buy) −2,146 32,185
2017-11-01 Schenkein David P Chief Executive Officer Option exercise +6,000 $0.30 $2K 6,000
2017-11-01 Schenkein David P Chief Executive Officer Sale −200 $66.75 $13K 5,800
2017-11-01 Schenkein David P Chief Executive Officer Sale −598 $65.42 $39K 5,202
2017-11-01 Schenkein David P Chief Executive Officer Sale −942 $64.64 $61K 4,260
2017-11-01 Schenkein David P Chief Executive Officer Sale −4,260 $63.32 $270K 0
2017-11-01 Schenkein David P Chief Executive Officer Option exercise · Stock option (right to buy) −6,000 26,656
2017-10-17 Cantley Lewis Clayton Jr. Director Sale −1,000 $71.10 $71K 83,394
2017-10-17 Cantley Lewis Clayton Jr. Director Sale −1,000 $71.10 $71K 83,434
2017-10-16 Cantley Lewis Clayton Jr. Director Sale −1,000 $71.09 $71K 84,394
2017-10-16 Cantley Lewis Clayton Jr. Director Sale −1,000 $71.09 $71K 84,434
2017-10-04 Biller Scott Chief Scientific Officer Sale −10,470 $70.00 $733K 0
2017-10-04 Schenkein David P Chief Executive Officer Option exercise +80,000 $0.30 $24K 80,000
2017-10-04 Schenkein David P Chief Executive Officer Sale −80,000 $70.14 $5.6M 0
2017-10-04 Schenkein David P Chief Executive Officer Option exercise · Stock option (right to buy) −80,000 32,656
2017-10-02 Biller Scott Chief Scientific Officer Option exercise +1,191 $9.05 $11K 7,455
2017-10-02 Biller Scott Chief Scientific Officer Sale −1,191 $67.23 $80K 6,264
2017-10-02 Biller Scott Chief Scientific Officer Option exercise +955 $31.64 $30K 7,219

Page 71 of 80 · 1,590 trades